MorphoSys AG Interest Expense 2011-2025 | MOR

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense MorphoSys AG

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.66 M	2.75 M	2.42 M	1.02 M	91 K	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
4.66 M	91 K	2.19 M

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Amphastar Pharmaceuticals AMPH	4.08 M	$ 25.27	-2.43 %	$ 1.22 B	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	459 K	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	2.95 M	$ 3.26	-3.12 %	$ 252 M	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Adaptimmune Therapeutics plc ADAP	-807 K	-	-15.15 %	$ 60.3 M	Britain
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Aeglea BioTherapeutics AGLE	-20.7 M	-	-	$ 1.01 B	USA
Ascendis Pharma A/S ASND	65.5 M	$ 220.27	4.81 %	$ 5 B	Danmark
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Enlivex Therapeutics Ltd. ENLV	874 K	$ 0.91	-5.01 %	$ 18.7 M	Israel
Can-Fite BioPharma Ltd. CANF	227 K	$ 0.28	-2.28 %	$ 609 M	Israel
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.3	-3.51 %	$ 7.94 B	Australia
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	-12.6 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	2.66 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	910 K	-	-7.31 %	$ 87 M	USA
Benitec Biopharma BNTC	-126 K	$ 12.05	-7.06 %	$ 496 M	USA
Aytu BioScience AYTU	-512 K	$ 2.34	2.59 %	$ 14.7 M	USA
Arena Pharmaceuticals ARNA	4.16 M	-	-6.81 %	$ 3.04 B	USA
Baudax Bio BXRX	1.36 M	-	0.59 %	$ 63 K	USA
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Catalyst Biosciences CBIO	1.04 M	$ 14.01	-8.49 %	$ 922 M	USA
ChromaDex Corporation CDXC	3 K	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	286 M	$ 566.18	-2.56 %	$ 42.9 B	USA
Cerus Corporation CERS	1.98 M	$ 2.16	0.47 %	$ 399 M	USA
Checkpoint Therapeutics CKPT	344 K	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-257 K	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	444 K	-	-7.23 %	$ 13 M	USA
Biogen BIIB	250 M	$ 174.42	1.11 %	$ 25.4 B	USA
BioVie BIVI	4.3 M	$ 1.42	-5.96 %	$ 2.1 M	USA
Celldex Therapeutics CLDX	927 K	$ 27.36	-2.09 %	$ 1.76 M	USA
Cortexyme CRTX	-102 K	-	-1.05 %	$ 67.1 M	USA
Deciphera Pharmaceuticals DCPH	16.4 M	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	-7.26 M	$ 11.54	0.87 %	$ 746 M	USA